冷链物流
Search documents
步步高涨2.03%,成交额5.77亿元,主力资金净流入3209.57万元
Xin Lang Zheng Quan· 2025-12-02 06:10
Core Viewpoint - The stock price of Bubugao has increased by 40% this year, with recent trading activity showing a slight upward trend, indicating potential investor interest and market confidence in the company [2]. Group 1: Stock Performance - As of December 2, Bubugao's stock rose by 2.03%, reaching 5.53 CNY per share, with a trading volume of 577 million CNY and a turnover rate of 4.92%, resulting in a total market capitalization of 14.869 billion CNY [1]. - Year-to-date, Bubugao's stock has seen a 40% increase, with a 2.60% rise over the last five trading days and a 5.94% increase over the last 20 days, although it has declined by 5.47% over the past 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Bubugao reported a revenue of 3.201 billion CNY, reflecting a year-on-year growth of 26.45%. However, the net profit attributable to shareholders was 226 million CNY, which represents a significant decrease of 88.83% compared to the previous year [2]. - The company has cumulatively distributed 1.677 billion CNY in dividends since its A-share listing, but there have been no dividend distributions in the last three years [3]. Group 3: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Bubugao increased to 172,500, marking a 95% rise from the previous period, while the average circulating shares per person decreased by 27.06% to 12,476 shares [2]. - Bubugao has appeared on the stock market's "Dragon and Tiger List" 10 times this year, with the most recent appearance on September 9, where it recorded a net buy of -51.528 million CNY [2].
广汇物流跌2.03%,成交额3798.29万元,主力资金净流出656.08万元
Xin Lang Zheng Quan· 2025-12-02 05:24
Core Viewpoint - Guanghui Logistics has experienced a significant decline in stock price and financial performance, indicating potential challenges in its operations and market position [1][2]. Financial Performance - As of November 20, 2025, Guanghui Logistics reported a revenue of 2.051 billion yuan, a year-on-year decrease of 20.09%, and a net profit attributable to shareholders of 318 million yuan, down 24.55% year-on-year [2]. - The company's stock price has dropped 29.83% year-to-date, with a recent decline of 2.03% in the last five trading days and 11.42% over the past 20 days [1]. Stock Market Activity - The stock price of Guanghui Logistics was 6.75 yuan per share, with a market capitalization of 8.055 billion yuan [1]. - The company has seen a net outflow of main funds amounting to 6.5608 million yuan, with significant selling pressure from large orders [1]. Shareholder Information - As of November 20, 2025, the number of shareholders increased by 29.51% to 24,600, while the average circulating shares per person decreased by 22.79% to 48,574 shares [2]. - The company has not distributed any dividends in the last three years, with a total payout of 1.343 billion yuan since its A-share listing [3]. Business Overview - Guanghui Logistics operates in the transportation and logistics sector, with its main revenue sources being energy logistics services (79.11%), real estate sales (16.38%), and logistics park operations (3.00%) [1]. - The company is involved in various concepts such as smart logistics, cold chain logistics, and the Belt and Road Initiative [2].
北部湾港涨2.86%,成交额1.96亿元,近5日主力净流入1204.49万
Xin Lang Cai Jing· 2025-12-01 13:00
Core Viewpoint - The company, Beibu Gulf Port, is a key player in the logistics and shipping industry, benefiting from strategic initiatives like the Belt and Road Initiative and the development of the Western Land-Sea New Corridor, which enhances its operational significance in the region [2][3]. Company Overview - Beibu Gulf Port is the only public terminal operator in the Guangxi Beibu Gulf region, focusing on container and bulk cargo handling, storage, and port services [3][8]. - The company operates as a crucial gateway for international trade, particularly towards ASEAN countries, and is involved in various logistics services including cold chain logistics [3][5]. Financial Performance - In 2023, the company achieved a cargo throughput of 31,039.78 million tons, a year-on-year increase of 10.81%, and a container throughput of 802.20 million TEUs, up 14.26% [3]. - For the period from January to September 2025, the company reported a revenue of 5.535 billion yuan, reflecting a year-on-year growth of 12.92%, while the net profit attributable to shareholders decreased by 13.89% to 789 million yuan [8]. Market Position and Strategy - The company is positioned as a major logistics hub in the western region of China, with a focus on enhancing its port operations and expanding its service offerings in collaboration with partners [2][3]. - The company has established multiple fruit shipping routes from Thailand, Vietnam, and Cambodia, and offers comprehensive cold chain logistics services [3]. Shareholder Information - As of September 30, 2025, the company had 59,400 shareholders, with a notable increase of 42.47% from the previous period [8]. - The top ten circulating shareholders include significant entities like the Southern CSI 500 ETF and Hong Kong Central Clearing Limited, indicating a diverse shareholder base [9].
苏豪汇鸿涨2.27%,成交额2.75亿元,主力资金净流入408.12万元
Xin Lang Cai Jing· 2025-12-01 03:26
Core Viewpoint - Suhao Huihong's stock price has shown significant growth this year, with a year-to-date increase of 22.57% and a recent surge of 12.10% over the last five trading days [1] Company Overview - Suhao Huihong Group Co., Ltd. is based in Nanjing, Jiangsu Province, established on October 13, 1992, and listed on June 30, 2004. The company specializes in supply chain operations, asset management, and industrial investment [1] - The revenue composition of the company includes bulk business (48.90%), green recycling (24.39%), fresh food (11.30%), others (9.42%), and textile and apparel (5.98%) [1] Financial Performance - For the period from January to September 2025, Suhao Huihong achieved a revenue of 38.602 billion yuan, representing a year-on-year growth of 8.49%. The net profit attributable to shareholders was 51.884 million yuan, showing a substantial increase of 162.05% [2] - The company has distributed a total of 1.555 billion yuan in dividends since its A-share listing, with 44.8487 million yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders for Suhao Huihong was 39,900, a decrease of 10.85% from the previous period. The average number of circulating shares per shareholder increased by 12.17% to 56,154 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest, holding 20.3789 million shares, an increase of 2.8849 million shares from the previous period [3]
北部湾港涨0.92%,成交额8267.06万元,后市是否有机会?
Xin Lang Cai Jing· 2025-11-28 09:53
5、根据公司官网的公司业务介绍,北部湾港具备水果进口、酒类进口、肉类进口及烟花出口等口岸资 质,为相关特色产品提供专业化和个性化的服务。开辟了5条泰国水果航线、2条越南水果航线、1条柬 埔寨水果航线,并可提供仓储、配送、海铁联运等全程冷链物流服务。 来源:新浪证券-红岸工作室 11月28日,北部湾港涨0.92%,成交额8267.06万元,换手率0.47%,总市值207.34亿元。 异动分析 航运概念+天然气+统一大市场+一带一路+冷链物流 1、公司所从事的主要业务是集装箱和散杂货的港口装卸、堆存及船舶港口服务。公司的主要业务有港 口装卸堆存、拖轮、理货和代理业务。 集装箱和散杂货的港口装卸、堆存及船舶港口服务。 2、公司持股49%的子公司国家管网集团广西防城港天然气有限责任公司,主营液化天然气存储、销 售,注册资本27000万元。 3、根据互动平台内容显示:北部湾港作为西部地区重要的出海通道和物流枢纽,推动货物"散改集"更 能有效的与腹地产业相结合,提升西部陆海新通道的受众范围,加快西部陆海新通道建设。公司开展的 资本运作主要是围绕港口主营业务,公司将坚持发展第一要务,紧扣港口生产经营中心工作,携手广大 客户 ...
金域医学涨2.05%,成交额3111.68万元,主力资金净流入111.39万元
Xin Lang Cai Jing· 2025-11-28 02:05
Core Viewpoint - The stock of Kingmed Diagnostics has shown a mixed performance in recent trading sessions, with a year-to-date increase of 12.08% but a decline over the past 60 days [1][2]. Company Overview - Kingmed Diagnostics, established on May 26, 2006, and listed on September 8, 2017, is based in Guangzhou, China. The company provides a wide range of diagnostic services to over 23,000 medical institutions across the country, covering nearly 80 types of testing technologies and approximately 3,200 testing projects [1]. - The main revenue sources for the company include: medical diagnostic services (91.20%), sales of diagnostics (6.45%), other services (1.47%), cold chain logistics (0.62%), and health check services (0.27%) [1]. Financial Performance - For the period from January to September 2025, Kingmed Diagnostics reported a revenue of 4.538 billion yuan, a year-on-year decrease of 19.23%. The net profit attributable to the parent company was -796.095 million yuan, reflecting a significant decline of 184.84% compared to the previous year [2]. - Since its A-share listing, the company has distributed a total of 2.545 billion yuan in dividends, with 1.647 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Kingmed Diagnostics was 41,700, a decrease of 1.60% from the previous period. The average number of tradable shares per shareholder increased by 1.62% to 11,042 shares [2]. - The top circulating shareholder, Hong Kong Central Clearing Limited, held 35.5057 million shares, a reduction of 2.8676 million shares from the previous period. The eighth largest shareholder, Hua Bao Zhong Zheng Medical ETF, held 7.8786 million shares, down by 1.2515 million shares [3].
鹭燕医药跌2.03%,成交额3512.11万元,主力资金净流出416.11万元
Xin Lang Cai Jing· 2025-11-28 01:57
Core Viewpoint - The stock of Luyuan Pharmaceutical has experienced fluctuations, with a recent decline of 2.03%, while the company shows a year-to-date stock price increase of 22.52% [1][2]. Financial Performance - For the period from January to September 2025, Luyuan Pharmaceutical achieved a revenue of 15.855 billion yuan, representing a year-on-year growth of 2.87%. However, the net profit attributable to shareholders decreased by 14.64% to 220 million yuan [2]. - Cumulatively, the company has distributed 728 million yuan in dividends since its A-share listing, with 369 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 28, the stock price was 9.63 yuan per share, with a market capitalization of 3.741 billion yuan. The trading volume was 35.1211 million yuan, with a turnover rate of 0.95% [1]. - The net outflow of main funds was 4.1611 million yuan, with significant selling pressure observed [1]. Business Overview - Luyuan Pharmaceutical, established on September 3, 2008, and listed on February 18, 2016, is based in Xiamen, Fujian Province. The company primarily engages in the distribution and retail of pharmaceuticals, traditional Chinese medicine, medical devices, and vaccines [1]. - The revenue composition of the company is as follows: pharmaceuticals 83.20%, medical devices 11.54%, traditional Chinese medicine 4.22%, and others 1.05% [1]. Shareholder Information - As of September 30, the number of shareholders was 22,700, a decrease of 3.01% from the previous period, while the average circulating shares per person increased by 3.10% to 16,784 shares [2].
被抖音清退的中通冷链,豪赌航空硬刚京东物流和顺丰?
3 6 Ke· 2025-11-26 04:26
Core Insights - The article discusses the critical importance of cold chain logistics for preserving the freshness of sensitive goods like fresh produce and pharmaceuticals, emphasizing the dual challenges of time and temperature control [2][3] - It highlights the competitive landscape for cold chain logistics, particularly focusing on Zhongtong's recent strategic moves to enhance its cold chain capabilities amid operational challenges and market competition [3][7] Group 1: Zhongtong's Cold Chain Strategy - Zhongtong has announced the launch of cold chain air express services and strategic partnerships to improve its logistics capabilities, marking a significant step in its cold chain market strategy [3][7] - The company faces significant challenges due to recent controversies involving false logistics information and operational inefficiencies, which have led to its removal from the Douyin platform [4][5][6] Group 2: Competitive Landscape - Zhongtong's cold chain logistics operations include over 1,200 cold chain logistics points, 37 distribution centers, and more than 2,200 cold chain vehicles, but it still lags behind competitors like JD Logistics and SF Express in terms of infrastructure and service capabilities [9][10] - JD Logistics has established a comprehensive cold chain service platform with extensive warehouse and transportation networks, while SF Express benefits from a strong brand reputation and efficient logistics operations [10][12] Group 3: Market Outlook - The global cold chain logistics market is projected to grow from $248.38 billion in 2020 to $335.33 billion by 2025, with a compound annual growth rate of 5.98%, driven primarily by the Asia-Pacific region [14]
中集车辆涨2.06%,成交额5583.74万元,主力资金净流出177.37万元
Xin Lang Zheng Quan· 2025-11-26 03:12
Core Viewpoint - CIMC Vehicles has experienced a stock price increase of 13.00% year-to-date, but has seen a recent decline of 2.08% over the past five trading days, indicating volatility in its stock performance [2]. Group 1: Stock Performance - As of November 26, CIMC Vehicles' stock price rose by 2.06% to 9.91 CNY per share, with a trading volume of 55.84 million CNY and a turnover rate of 0.39%, resulting in a total market capitalization of 18.573 billion CNY [1]. - The stock has shown a 6.67% increase over the past 20 days and a 9.26% increase over the past 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, CIMC Vehicles reported a revenue of 15.012 billion CNY, reflecting a year-on-year decrease of 5.13%, while the net profit attributable to shareholders was 622 million CNY, down 26.23% year-on-year [2]. - The company has distributed a total of 2.664 billion CNY in dividends since its A-share listing, with 1.655 billion CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for CIMC Vehicles was 29,800, a decrease of 16.07% from the previous period, with an average of 48,786 circulating shares per shareholder, an increase of 19.17% [2]. - Among the top ten circulating shareholders, Dazheng Gaoxin Stock A (000628) is the sixth largest, holding 25.058 million shares, which is a reduction of 5.029 million shares compared to the previous period [3].
中集集团涨2.06%,成交额3.94亿元,主力资金净流入4877.54万元
Xin Lang Cai Jing· 2025-11-25 06:11
资金流向方面,主力资金净流入4877.54万元,特大单买入5595.39万元,占比14.21%,卖出3159.79万 元,占比8.03%;大单买入9338.13万元,占比23.72%,卖出6896.19万元,占比17.52%。 中集集团今年以来股价涨10.98%,近5个交易日跌1.98%,近20日涨3.06%,近60日涨2.55%。 11月25日,中集集团盘中上涨2.06%,截至13:41,报8.43元/股,成交3.94亿元,换手率2.05%,总市值 454.59亿元。 责任编辑:小浪快报 截至9月30日,中集集团股东户数11.59万,较上期减少13.00%;人均流通股19866股,较上期增加 14.94%。2025年1月-9月,中集集团实现营业收入1170.61亿元,同比减少9.23%;归母净利润15.66亿 元,同比减少14.35%。 分红方面,中集集团A股上市后累计派现186.38亿元。近三年,累计派现20.33亿元。 机构持仓方面,截止2025年9月30日,中集集团十大流通股东中,南方中证500ETF(510500)位居第八 大流通股东,持股2677.52万股,相比上期减少56.14万股。 资料显示, ...